Total Payments
$32,763
2024 Payments
$760.82
Companies
48
Transactions
196
Medicare Patients
5,192
Medicare Billing
$3.5M
Payment Breakdown by Category
Consulting$27,500 (83.9%)
Food & Beverage$4,263 (13.0%)
Other$1,000 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,500 | 10 | 83.9% |
| Food and Beverage | $4,263 | 185 | 13.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $17,901 | 20 | $0 (2023) |
| AUGMENIX, INC. | $11,567 | 19 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $398.52 | 20 | $0 (2023) |
| Janssen Biotech, Inc. | $346.58 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $281.06 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $201.24 | 10 | $0 (2024) |
| EMD Serono, Inc. | $143.19 | 7 | $0 (2023) |
| ABBVIE INC. | $131.40 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $129.03 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $122.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $760.82 | 30 | Takeda Pharmaceuticals U.S.A., Inc. ($98.15) |
| 2023 | $796.53 | 32 | Regeneron Healthcare Solutions, Inc. ($122.91) |
| 2022 | $815.19 | 43 | Merck Sharp & Dohme LLC ($130.70) |
| 2021 | $330.14 | 16 | Janssen Biotech, Inc. ($147.62) |
| 2020 | $3,684 | 11 | Boston Scientific Corporation ($3,566) |
| 2019 | $18,956 | 28 | Boston Scientific Corporation ($14,233) |
| 2018 | $6,071 | 23 | Augmenix, Inc. ($5,879) |
| 2017 | $1,349 | 13 | AUGMENIX, INC. ($1,188) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Davol Inc. | Progel Applicator Spray Tips (Device) | Food and Beverage | In-kind items and services | $41.22 | General |
| Category: Surgery | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Oncology | ||||||
| 09/10/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Oncology | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Oncology | ||||||
| 08/02/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Oncology | ||||||
| 06/26/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $36.08 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $25.53 | General |
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Oncology | ||||||
| 05/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
| 04/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $39.80 | General |
| 03/06/2024 | VisionRT, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,180 | 3,639 | $2.0M | $703,451 |
| 2022 | 23 | 1,468 | 5,192 | $2.8M | $966,819 |
| 2021 | 23 | 1,467 | 5,642 | $3.2M | $1.1M |
| 2020 | 27 | 1,077 | 4,232 | $2.3M | $750,103 |
Total Patients
5,192
Total Services
18,705
Medicare Billing
$3.5M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 108 | 882 | $815,850 | $245,706 | 30.1% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 59 | 66 | $236,874 | $93,416 | 39.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 116 | 887 | $262,552 | $83,416 | 31.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 111 | 312 | $100,776 | $46,795 | 46.4% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 27 | 52 | $129,844 | $40,658 | 31.3% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 60 | 83 | $71,629 | $30,231 | 42.2% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 28 | 129 | $75,465 | $23,328 | 30.9% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 80 | 326 | $43,684 | $21,715 | 49.7% |
| 77771 | High dose radiation therapy, 2-12 channels | Office | 2023 | 12 | 33 | $36,795 | $15,532 | 42.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 93 | 93 | $32,550 | $15,304 | 47.0% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 17 | 65 | $38,025 | $11,922 | 31.4% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 88 | 89 | $26,878 | $11,691 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 170 | $21,250 | $11,313 | 53.2% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 86 | 112 | $29,792 | $10,768 | 36.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 75 | 209 | $23,826 | $10,743 | 45.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 29 | 51 | $23,715 | $10,739 | 45.3% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 28 | 29 | $25,491 | $10,076 | 39.5% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 13 | 13 | $14,716 | $6,578 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 26 | $4,732 | $2,203 | 46.6% |
| 77470 | Special radiation treatment | Office | 2023 | 12 | 12 | $5,580 | $1,316 | 23.6% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 179 | 1,374 | $1.3M | $390,674 | 30.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 189 | 1,393 | $412,328 | $131,359 | 31.9% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 55 | 59 | $211,751 | $84,223 | 39.8% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 126 | 385 | $124,355 | $57,800 | 46.5% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2022 | 26 | 56 | $139,832 | $44,299 | 31.7% |
About Dr. Eric Gross, MD
Dr. Eric Gross, MD is a Radiation Oncology healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336135516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Gross, MD has received a total of $32,763 in payments from pharmaceutical and medical device companies, with $760.82 received in 2024. These payments were reported across 196 transactions from 48 companies. The most common payment nature is "Consulting Fee" ($27,500).
As a Medicare-enrolled provider, Gross has provided services to 5,192 Medicare beneficiaries, totaling 18,705 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Chandler, AZ
- Active Since 09/23/2005
- Last Updated 03/30/2020
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1336135516
Products in Payments
- SPACEOAR (Device) $17,691
- SpaceOAR (Device) $11,567
- Xofigo (Drug) $335.53
- KEYTRUDA (Biological) $281.06
- LIBTAYO (Biological) $141.55
- IMBRUVICA (Drug) $115.20
- ERLEADA (Drug) $111.93
- LUPRON DEPOT (Drug) $111.56
- FIRMAGON (Drug) $103.01
- SpaceOAR VUE System - 10mL (Device) $101.97
- KISQALI (Drug) $95.93
- XTANDI (Drug) $92.18
- BAVENCIO (Drug) $85.35
- Enhertu (Drug) $79.66
- GENERAL THERAPIES (Device) $71.32
- NINLARO (Drug) $66.96
- ORGOVYX (Drug) $64.06
- Da Vinci Surgical System (Device) $62.36
- FOTIVDA (Drug) $50.83
- Tazverik (Drug) $47.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.